Last reviewed · How we verify
Recombinant herpes zoster vaccine with high-dose adjuvant
Recombinant herpes zoster vaccine with high-dose adjuvant is a Biologic drug developed by Shanghai Institute Of Biological Products. It is currently in Phase 1 development.
At a glance
| Generic name | Recombinant herpes zoster vaccine with high-dose adjuvant |
|---|---|
| Sponsor | Shanghai Institute Of Biological Products |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals (PHASE1, PHASE2)
- A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older (PHASE2)
- Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older (PHASE1)
- Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above (PHASE1)
- A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Recombinant herpes zoster vaccine with high-dose adjuvant CI brief — competitive landscape report
- Recombinant herpes zoster vaccine with high-dose adjuvant updates RSS · CI watch RSS
- Shanghai Institute Of Biological Products portfolio CI
Frequently asked questions about Recombinant herpes zoster vaccine with high-dose adjuvant
What is Recombinant herpes zoster vaccine with high-dose adjuvant?
Recombinant herpes zoster vaccine with high-dose adjuvant is a Biologic drug developed by Shanghai Institute Of Biological Products.
Who makes Recombinant herpes zoster vaccine with high-dose adjuvant?
Recombinant herpes zoster vaccine with high-dose adjuvant is developed by Shanghai Institute Of Biological Products (see full Shanghai Institute Of Biological Products pipeline at /company/shanghai-institute-of-biological-products).
What development phase is Recombinant herpes zoster vaccine with high-dose adjuvant in?
Recombinant herpes zoster vaccine with high-dose adjuvant is in Phase 1.